2026.09 Three-year research plan (2026–2029) adopted in molecular diagnostics and computational pathology

2024.10 Two abstracts published in the American Journal of Clinical Pathology (Vol. 162, Suppl. 1)

2024.09 Two posters presented at the American Society for Clinical Pathology (ASCP) 2024 Annual Meeting, Chicago

2023 Patient referrals to Hilly PMC Clinic (Jeju and Hwaseong, Korea) for personalized cancer care

2022.07  Two posters presented at the 13th Cancer Genomics Consortium Annual Meeting, St. Louis

2022 Cancer testing development begins

2022 Pre-EUA submission to the U.S. FDA for antigen testing

2022.01 Press: “GG Omicron and Delta PCR Testing for Clinical Triage of COVID Patients,” Hudson Weekly, January 7, 2022 (same article also ran on Big News Network, Madison Graph, Lincoln Citizen, Belmont Star and Fairmont Post)

2021.12 Press: Yakup (약업신문), “Cellgenemedix develops PCR kit for simultaneous Delta and Omicron diagnosis,” December 20, 2021; also covered by Medipana and Pharmstock

2021.12 Technical report published on Zenodo: “Development of accurate SARS-CoV-2 RT-PCR with Omicron/stealth/Delta diagnosis”

2022 EUA submission to the U.S. FDA for Antigen testing

2021 Pre-EUA submission to the U.S. FDA for PCR testing

2020.05 CellGeneMedix LLC formed in New Jersey